IMCC
Health Care

IM Cannabis Corp.

IMCC
Since 1993

Headquarters:

Israel

Exchange:

NASDAQ

Industry:

Drug Manufacturers—Specialty & Generic

Number of Employees:

95.00

Current Fiscal Year:

2024

Market Cap:

5.21M

Price per Share:

$1.69

Quarterly Dividend per Share:

Year-to-date Performance:
-25.8772%
Dividend Yield:
%
Price-to-book Ratio:
0.88
Trailing P/E Ratio:
N/A

Price History

Latest Prices

DateOpenHighLowClose
2025-04-301.511.741.461.69
2025-04-291.41.581.41.5
2025-04-281.441.4651.441.44
2025-04-251.531.591.411.42
2025-04-241.581.70991.421.53

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.

Financial Performance

2024 Revenue:77.13M

Detailed view of quarterly revenue

2024 Net Income:-17.32M

Detailed view of quarterly net income

2024 Free Cash Flow:2.75M

Overview of free cash flow for the quarter

Annual Revenue Comparison

Compares total annual revenues

Similar Companies